Form 4: BIOXYTRAN Director Boosts Preferred Share Holdings

BIOXYTRAN Director Radka Milanova acquired additional preferred shares in two separate transactions, increasing her beneficial ownership.

Summary

• Radka Milanova, a Director of BIOXYTRAN, INC, reported two acquisitions of preferred shares.
• On August 12, 2025, she acquired 10,417 preferred shares at a price of $0.485 per share.
• Following this transaction, her beneficial ownership of preferred shares increased to 165,100.
• On November 14, 2025, she acquired an additional 38,588 preferred shares at $0.35 per share.
• This second transaction brought her total beneficial ownership of preferred shares to 203,688.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director increasing their beneficial ownership in the company through multiple share acquisitions, signaling confidence in the company's future.

Positives

• A Director, Radka Milanova, increased her stake in the company by acquiring a total of 49,005 preferred shares across two transactions.
• The acquisitions demonstrate management's confidence in the company's future prospects.

Industry Context

Insider transactions, such as those reported in a Form 4, are closely watched by investors as they can signal management's perception of the company's intrinsic value, independent of broader industry trends. While not directly related to industry-wide performance, significant insider buying can be interpreted as a positive indicator within the company's specific sector.

Related Party Transactions

• The reported transactions involve a director of BIOXYTRAN, INC acquiring company securities, which constitutes a related party transaction under SEC regulations.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal, potentially boosting investor confidence in the company's prospects.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

BIOXYTRAN, BIXT, Form 4, insider buying, beneficial ownership, preferred stock, director, Radka Milanova, equity acquisition